Acceleron Pharma reported $12M in Trade Creditors for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 12M 9M
Akebia Therapeutics AKBA:US $ 40.4M 10.99M
Amgen AMGN:US $ 1150M 188M
Bayer BAYN:GR 509.8M 23.3M
Bluebird Bio BLUE:US $ 26.18M 4.35M
Clovis Oncology CLVS:US $ 24M 12M
Dicerna Pharmaceuticals DRNA:US $ 7.25M 0.52M
Eli Lilly And LLY:US $ 1247.2M 39.5M
Exelixis EXEL:US $ 9M 6M
Gilead Sciences GILD:US $ 532M 58M
Johnson & Johnson JNJ:US $ 7044M 279M
Novartis NOVN:VX 4.82B 8M
Pfizer PFE:US $ 3872M 100M
Ptc Therapeutics PTCT:US $ 15.46M 0.61M
Puma Biotechnology PBYI:US $ 11M 6M
Regeneron Pharmaceuticals REGN:US $ 380.1M 32.3M
Ultragenyx Pharmaceutical RARE:US $ 9.01M 5.39M
Vertex Pharmaceuticals VRTX:US $ 101.45M 0.75M